Maloca, Peter M. http://orcid.org/0000-0002-4794-5859
Müller, Philipp L. http://orcid.org/0000-0003-1680-0224
Lee, Aaron Y.
Tufail, Adnan
Balaskas, Konstantinos
Niklaus, Stephanie
Kaiser, Pascal
Suter, Susanne http://orcid.org/0000-0002-7998-7930
Zarranz-Ventura, Javier http://orcid.org/0000-0003-2338-8143
Egan, Catherine
Scholl, Hendrik P. N.
Schnitzer, Tobias K.
Singer, Thomas
Hasler, Pascal W.
Denk, Nora
Funding for this research was provided by:
This research was supported by Roche, Switzerland.
Article History
Received: 17 June 2020
Accepted: 13 January 2021
First Online: 5 February 2021
Competing interests
: Research support was granted from Roche, Basel, Switzerland, especially with data collection and the decision to publish. Roche had no role and did not interfere in conceptualization or conduct of this study. Authors P.K. and S.S. are salaried employees of Supercomputing Systems, Zurich; Authors S.N., T.K.S., T.S. and N.D. are salaried employees of Roche, Basel, Switzerland; P.M.M. is a consultant at Roche, Basel, Switzerland. The other authors of this paper declare no competing interests. Outside of the present study, the authors declare the following competing interests: P.M.M. is a consultant at Zeiss Forum and holds intellectual properties for machine learning at MIMO AG, and VisionAI, Switzerland. A.Y.L. has received funding from Novartis, Microsoft Corporation, NVIDIA Corporation and grant number from NEI: K23EY029246. P.L.M. received funding by the German Research Foundation (grant # MU4279/2–1). C.E. and A.T. received a financial grant from the National Institute for Health Research (NIHR) Biomedical Research Centre, based at Moorfields Eye Hospital, and also from the NHS Foundation Trust and the UCL Institute of Ophthalmology. The views expressed in this article are those of the authors and not necessarily those of the National Eye Institute, NHS, the NIHR, or the Department of Health. A.T. is a consultant for Heidelberg Engineering and Optovue and has received research grant funding from Novartis and Bayer. C.E. is a consultant for Heidelberg Engineering and has received research grant funding from Novartis. J.Z.-V. is a consultant or has received travel grants of Alcon, Alimera Sciences, Allergan, Bausch&Lomb, Bayer, Brill Pharma, Novartis or Topcon.